• Vetiranary Medicine
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Pennsylvania proposal to enforce drug-risk disclosure

June 1, 2006

Harrisburg, Pa.- Pennsylvania lawmakers are considering tough legislation mandating drug-risk disclosure and prescreening animals prior to pharmaceutical use if recommended by a drug maker.

HARRISBURG, PA.— Pennsylvania lawmakers are considering tough legislation mandating drug-risk disclosure and prescreening animals prior to pharmaceutical use if recommended by a drug maker.

Pennsylvania bills, S.B. 1144 and S.B. 1145, were introduced by Sen. Michael J. Stack "to provide greater disclosure and protection to pet owners."

Both bills were referred to the state's Consumer Protection and Professional Licensure Committee. This legislation likely won't take flight "anytime soon," reports Dr. Michael Moyer, chair of the Pennsylvania Veterinary Medical Association's legislative committee.

Advertisement

Instead, large-scale statewide issues like gambling and property tax relief will trump Pennsylvania's legislative agenda this election year, he believes.

"We have some concerns with the language. All of the issues underneath it are well within the scope of the regulatory process. The state board of veterinary medicine is well equipped to take on all these issues," Moyer contends.

S.B. 1145 amends the state's veterinary practice act and also calls for disciplinary proceedings if a veterinarian fails to pre-screen an animal prior to use of a drug as recommended by a pharmaceutical manufacturer. "The veterinarian board may consider the withholding of consent for any prescreening by the animal owner when determining if a veterinarian should be disciplined."

The second piece of legislation, S.B. 1144, would require veterinarians dispense client information sheets detailing potential adverse drug events prior to a drug's administration.

"Client information sheets are dispensed with each package of prescription drugs sold to veterinarians. Client information sheets are produced for drugs that could seriously or fatally harm animals," Stack writes in a memorandum to other Pennsylvania senators.

Stack introduced the legislation at the request of a constituent who lost her dog to a lethal interaction with the popular non-steroidal anti-inflammatory drug Rimadyl. The animal's veterinarian allegedly did not offer an adverse event information sheet or take blood tests prior to prescribing the drug.

— By Daniel R. Verdon, Editor; reported by Jennifer Fiala, Senior Editor


Advertisement

Latest News

Managing wounds in pet patients

Spectrum of care: protocols to support pet owners’ budgets

How to support women while still running a successful business

The Vets expands to Raleigh, NC

View More Latest News
Advertisement